Genelex Corp

30,000 breast cancer survivors taking tamoxifen are being put unnecessarily at risk of a reccurence due to slow adoption of a simple genetic test.

The published reports of Mr. Jackson's medications illustrate an important issue- any two drugs may be safe in combination but the cumulative effect of many drugs can be difficult to detect and very dangerous.